Publication | Open Access
Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial
38
Citations
33
References
2020
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1